GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Universal Ibogaine Inc (TSXV:IBO) » Definitions » Market Cap

Universal Ibogaine (TSXV:IBO) Market Cap : C$4.37 Mil (As of May. 27, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Universal Ibogaine Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Universal Ibogaine's share price for the quarter that ended in Jan. 2024 was C$0.01. Universal Ibogaine's Shares Outstanding (EOP) for the quarter that ended in Jan. 2024 was 191.79 Mil. Therefore, Universal Ibogaine's market cap for the quarter that ended in Jan. 2024 was C$1.92 Mil.

Universal Ibogaine's quarterly market cap declined from Jul. 2023 (C$2.88 Mil) to Oct. 2023 (C$0.96 Mil) but then increased from Oct. 2023 (C$0.96 Mil) to Jan. 2024 (C$1.92 Mil).

Universal Ibogaine's annual market cap increased from Mar. 2021 (C$1.93 Mil) to Jul. 2022 (C$7.63 Mil) but then declined from Jul. 2022 (C$7.63 Mil) to Jul. 2023 (C$2.88 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Universal Ibogaine's Enterprise Value for Today is C$6.80 Mil.


Universal Ibogaine Market Cap Historical Data

The historical data trend for Universal Ibogaine's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Universal Ibogaine Market Cap Chart

Universal Ibogaine Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Jul22 Jul23
Market Cap
Get a 7-Day Free Trial 1.87 1.79 1.93 7.63 2.88

Universal Ibogaine Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.83 2.87 2.88 0.96 1.92

Competitive Comparison of Universal Ibogaine's Market Cap

For the Biotechnology subindustry, Universal Ibogaine's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Universal Ibogaine's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Universal Ibogaine's Market Cap distribution charts can be found below:

* The bar in red indicates where Universal Ibogaine's Market Cap falls into.



Universal Ibogaine Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Universal Ibogaine's Market Cap for the fiscal year that ended in Jul. 2023 is calculated as

Market Cap (A: Jul. 2023 )=Share Price (A: Jul. 2023 )*Shares Outstanding (EOP) (A: Jul. 2023 )
=C$0.015*191.719
=C$2.88

Universal Ibogaine's Market Cap for the quarter that ended in Jan. 2024 is calculated as

Market Cap (Q: Jan. 2024 )=Share Price (Q: Jan. 2024 )*Shares Outstanding (EOP) (Q: Jan. 2024 )
=C$0.01*191.794
=C$1.92

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Universal Ibogaine  (TSXV:IBO) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Universal Ibogaine Market Cap Related Terms

Thank you for viewing the detailed overview of Universal Ibogaine's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Universal Ibogaine (TSXV:IBO) Business Description

Traded in Other Exchanges
Address
400 3rd Avenue South west, Suite 1470, Calgary, AB, CAN, T2P 4H2
Universal Ibogaine Inc develops a platform of addiction treatment clinics, which use ibogaine as a primary modality for the interruption and ideally cessation of addictions to primarily opioids such as oxycodone, heroin, fentanyl, as well as alcohol, cocaine, and other stimulants. It runs addiction clinics it has a research partner clinic in Mexico.

Universal Ibogaine (TSXV:IBO) Headlines

No Headlines